Figure 5
Figure 5. Effect of S1P on hMC functions. Purified cord blood–derived mast cells (hMCs) were treated with vehicle, increasing concentrations of S1P (1 nM, 10 nM, 100 nM, 1 μM), or ionomycin (1 μM) for 2 hours, or sensitized overnight with anti-DNP IgE (1 μg/mL) washed, and then stimulated with increasing concentrations of Ag (10, 30, 100 ng/mL) for 2 hours. Degranulation was assessed by β-hexosaminidase release (A), and secretion of CCL2 was measured by ELISA (B). Data are the means plus or minus SD of triplicate determinations from a single experiment. Similar results were obtained using cells from 2 different donors. (C) Migration of IgE-sensitized hMCs toward increasing concentrations of S1P (1, 10 μM), Ag (30 ng/mL), or FN (20 μg/mL) was determined in transwell chambers.

Effect of S1P on hMC functions. Purified cord blood–derived mast cells (hMCs) were treated with vehicle, increasing concentrations of S1P (1 nM, 10 nM, 100 nM, 1 μM), or ionomycin (1 μM) for 2 hours, or sensitized overnight with anti-DNP IgE (1 μg/mL) washed, and then stimulated with increasing concentrations of Ag (10, 30, 100 ng/mL) for 2 hours. Degranulation was assessed by β-hexosaminidase release (A), and secretion of CCL2 was measured by ELISA (B). Data are the means plus or minus SD of triplicate determinations from a single experiment. Similar results were obtained using cells from 2 different donors. (C) Migration of IgE-sensitized hMCs toward increasing concentrations of S1P (1, 10 μM), Ag (30 ng/mL), or FN (20 μg/mL) was determined in transwell chambers.

Close Modal

or Create an Account

Close Modal
Close Modal